Sarepta Therapeutics, Inc.

( )
SRPT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.28%182.000.7%$1407.54m
MRKMerck & Co., Inc. -0.25%93.040.7%$1238.33m
PFEPfizer Inc. -0.17%51.610.9%$1232.04m
BMYBristol-Myers Squibb Co. -0.03%78.971.0%$1137.12m
LLYEli Lilly & Co. 0.10%326.001.1%$1137.12m
ABBVAbbVie, Inc. 0.13%152.751.9%$1020.59m
AZNAstraZeneca Plc -1.61%65.821.0%$444.79m
SGENSeagen Inc. -0.18%179.005.7%$325.41m
GSKGSK Plc -0.85%43.320.2%$294.92m
TPTXTurning Point Therapeutics, Inc. 0.00%75.170.0%$291.93m
MRTXMirati Therapeutics, Inc. 2.70%70.001.6%$204.79m
SIGASIGA Technologies, Inc. -10.89%11.620.0%$195.76m
HZNPHorizon Therapeutics Plc 0.00%85.135.4%$182.59m
NVSNovartis AG -0.19%84.660.2%$167.44m
NVONovo Nordisk A/S 0.10%112.280.1%$147.50m

Company Profile

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.